Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.
Status:
Completed
Trial end date:
2014-09-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics (PK), metabolism, routes and
extent of elimination, safety and tolerability of a single oral dose of [14C] BMS-955176 in
healthy male subjects. There is no formal research hypothesis to be statistically tested for
this study.